Journal list Promote Sponsor
verified SJR 1,044 · Q1 • database Scopus / SJR & Web of Science indexed
Drug Metabolism Reviews
United States · Informa Healthcare
workspace_premium Q1 — Pharmacology (medical) lock Subscription

Drug Metabolism Reviews

Drug Metabolism Reviews is a journal indexed in SJR in Pharmacology (medical) and Pharmacology, Toxicology and Pharmaceutics (miscellaneous) with an H index of 113. It has an SJR impact factor of 1,044 and it has a best quartile of Q1. It is published in English. It has an SJR impact factor of 1,044.

Drug Metabolism Reviews focuses its scope in these topics and keywords: origin, graft, hepatotoxicity, mechanisms, processing, significance, pharmacokinetics, physiologically, pharmacokinetic, functionalitypm, ...

ISSN: 0360-2532
Publisher: Informa Healthcare
Category: Pharmacology (medical)
Indexation: verifiedScopus / SJR verifiedWeb of Science
open_in_new Portal NPD menu_book Guidelines NPD
schedule CountryOfPapers database fields
SJR Impact Factor trending_up
1,044 Q1
H-index 113
Acceptance rate pie_chart
24% Selective
Source Acceptance_Rate
Time to publication hourglass_top
NPD
Field NPD
Publication cost (APC) payments
NPD Subscription
Non-OA path NPD

Metrics

Scimago and CountryOfPapers database fields

Scopus / SJR Web of Science

SJR Impact

1,044

H-index

113

Docs (year)

24

Docs 3y

71

Total refs

3038

Cites 3y

317

Citable 3y

71

Cites/Doc 2y

4

Ref/Doc

126.58

Immediate OA

—

Embargoed OA

NPD

Non OA / Submission

—

shield Researcher voice

Name good journals. Call out predatory ones.

Share what peer review, fees, and timelines were really like. Praise fair editors. Flag APC traps, fake metrics, or spam solicitations — with facts from your submission.

Fair & fast peer review Clear APC / no surprise fees Suspected predatory Fake impact claims
rate_review Write an honest review

Researcher reviews

sentiment_dissatisfied No reviews yet — be the first to share an honest experience.
User
* Only to validate authenticity — identity is not shown publicly.

Best articles by citations

Clinical Relevance of Pharmacogenetics

View more

Xenobiotic-sensing nuclear receptors involved in drug metabolism: a structural perspective

View more

DEVELOPMENT AND UTILIZATION OF PRIMARY HEPATOCYTE CULTURE SYSTEMS TO EVALUATE METABOLISM, DNA BINDING, AND DNA REPAIR OF XENOBIOTICS*

View more

David Kupfer: A Career Retrospective

View more

David Kupfer, Ph.D. A Mentor and a Scientist

View more

David Kupfer at Meetings and Play

View more

David Kupfer and the Metabolism Connection: On Aromatase Inhibitors and Tamoxifen

View more

Cytochromes P450 - A Family of Proteins and Scientists-Understanding their Relationships

View more

Cytochrome P450IIe1: Roles in Nitrosamine Metabolism and Mechanisms of Regulation

View more

CYTOCHROME P450-NULL MICE

View more

CRYOPRESERVED PRIMARY HEPATOCYTES AS A CONSTANTLY AVAILABLE IN VITRO MODEL FOR THE EVALUATION OF HUMAN AND ANIMAL DRUG METABOLISM AND ENZYME INDUCTION*

View more

Coordinate Regulation of Drug Metabolism by Xenobiotic Nuclear Receptors: UGTs Acting Together with CYPs and Glucuronide Transporters

View more
SHOW MORE ARTICLES

Concluding remarks

View more

A Photographic Diary of Travels with David Kupfer

View more

Clinical Relevance of P-Glycoprotein in Drug Therapy

View more

Captopril: Pharmacology, Metabolism, and Disposition

View more

BIOREDUCTIVELY ACTIVATED ANTITUMORN-OXIDES: THE CASE OF AQ4N, A UNIQUE APPROACH TO HYPOXIA-ACTIVATED CANCER CHEMOTHERAPY

View more

BIOCHEMICAL DIVERSITY OF PEPTIDE-HORMONE-DEPENDENT REGULATION OF STEROIDOGENIC P450S

View more

BENZYLAMINE ANALOG BINDING STUDIES AS PROBES OF THE SUBSTRATE SITES OF MONOAMINE OXIDASES A AND B*

View more

APPLICATIONS OF PHARMACOGENETICS TO DRUG DEVELOPMENT: THE GLAXO WELLCOME EXPERIENCE*

View more

Antioxidant Enzymes and Apoptosis

View more

Alternative Approaches to Estimation of Population Pharmacokinetic Parameters: Comparison with the Nonlinear Mixed-Effect Model

View more

ALFRED HILDEBRANDT: FROM BASIC RESEARCH TO CLINICAL APPLICATION AND DRUG REGULATION

View more

Activated Estrogens and Antiestrogens: A 30-Year Journey with David Kupfer

View more

FAQs